2,681
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Harmful at non-cytotoxic concentrations: SiO2-SPIONs affect surfactant metabolism and lamellar body biogenesis in A549 human alveolar epithelial cells

, , , , , & show all
Pages 419-429 | Received 06 Oct 2016, Accepted 17 Mar 2017, Published online: 13 Apr 2017

References

  • Agassandian M, Mallampalli RK. 2013. Surfactant phospholipid metabolism. Biochim Biophys Acta 1831:612–25.
  • Anderson N, Borlak J. 2006. Drug-induced phospholipidosis. FEBS Lett 580:5533–40.
  • Andreeva AV, Kutuzov MA, Voyno-Yasenetskaya TA. 2007. Regulation of surfactant secretion in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 293:L259–71.
  • Arick DQ, Choi YH, Kim HC, Won YY. 2015. Effects of nanoparticles on the mechanical functioning of the lung. Adv Colloid Interface Sci 225:218–28.
  • Baber O, Jang M, Barber D, Powers K. 2011. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro BEAS-2B cells. Inhal Toxicol 23:532–43.
  • Bauch C, Bevan S, Woodhouse H, Dilworth C, Walker P. 2015. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach. Toxicol In Vitro 29:621–30.
  • Blank F, Rothen-Rutishauser BM, Schurch S, Gehr P. 2006. An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med 19:392–405.
  • Currie E, Schulze A, Zechner R, Walther TC, Farese RV. 2013. Cellular fatty acid metabolism and cancer. Cell Metab 18:153–61.
  • Davoren M, Herzog E, Casey A, Cottineau B, Chambers G, Byrne HJ, Lyng FM. 2007. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol In Vitro 21:438–48.
  • Doursout MF, Deshpande S, Williams GW. 2016. Respiratory physiology. Basic anesthesiology examination review. Oxford: Oxford University Press, 271.
  • Dwivedi M, Sachan AK, Galla HJ. 2014. Interaction of nanoparticles with lipid monolayers and lung surfactant films. Measuring biological impacts of nanomaterials. Basel: Springer International Publishing, 109–33.
  • Escamilla-Rivera V, Uribe-Ramirez M, Gonzalez-Pozos S, Velumani S, Arreola-Mendoza L, De Vizcaya-Ruiz A. 2016. Cytotoxicity of semiconductor nanoparticles in A549 cells is attributable to their intrinsic oxidant activity. J Nanopart Res 18:85.
  • Esposito V, Lucariello A, Savarese L, Cinelli M, Ferraraccio F, Bianco A, et al. 2012. Morphology changes in human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM1.0) and pollen allergens. Environ Pollut 171:162–7.
  • Esquivel-Gaon M, Anguissola S, Garry D, Gallegos-Melgar AD, Saldana JM, Dawson KA, et al. 2015. Bismuth-based nanoparticles as the environmentally friendly replacement for lead-based piezoelectrics. Rsc Adv 5:27295–304.
  • Glasser SW, Burhans MS, Korfhagen TR, Na CL, Sly PD, Ross GF, et al. 2001. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 98:6366–71.
  • Griese M, Reinhardt D. 1998. Smaller sized particles are preferentially taken up by alveolar type II pneumocytes. J Drug Target 5:471–9.
  • Haitsma JJ. 2007. Physiology of mechanical ventilation. Crit Care Clin 23:117–34.
  • Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, Teeguarden JG. 2010. ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 7:36.
  • Kralj S, Rojnik M, Romih R, Jagodic M, Kos J, Makovec D. 2012. Effect of surface charge on the cellular uptake of fluorescent magnetic nanoparticles. J Nanopart Res 14:1151.
  • Lesniak A, Salvati A, Santos-Martinez MJ, Radomski MW, Dawson KA, Åberg C. 2013. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc 135:1438–44.
  • Ma JY, Zhao H, Mercer RR, Barger M, Rao M, Meighan T, et al. 2011. Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology 5:312–25.
  • Mansour HM, Rhee YS, Wu X. 2009. Nanomedicine in pulmonary delivery. Int J Nanomedicine 4:299–319.
  • Marchi S, Patergnani S, Pinton P. 2014. The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim Biophys Acta 1837:461–9.
  • Moret F, Selvestrel F, Lubian E, Mognato M, Celotti L, Mancin F, Reddi E. 2015. PEGylation of ORMOSIL nanoparticles differently modulates the in vitro toxicity toward human lung cells. Arch Toxicol 89:607–20.
  • Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival – application to proliferation and cyto-toxicity assays. J Immunol Methods 65:55–63.
  • Mukherjee SG, O'Claonadh N, Casey A, Chambers G. 2012. Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines. Toxicol In Vitro 26:238–51.
  • Nowak JS, Mehn D, Nativo P, Garcia CP, Gioria S, Ojea-Jimenez I, et al. 2014. Silica nanoparticle uptake induces survival mechanism in A549 cells by the activation of autophagy but not apoptosis. Toxicol Lett 224:84–92.
  • Patel B, Gupta N, Ahsan F. 2015. Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome. Eur J Pharm Biopharm 89:163–74.
  • Penno A, Hackenbroich G, Thiele C. 2013. Phospholipids and lipid droplets. Biochim Biophys Acta 1831:589–94.
  • Pentchev P, Gal A, Booth A, Omodeo-Sale F, Fours J, Neumeyer B, et al. 1980. A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase. Biochim Biophys Acta 619:669–79.
  • Perez-Gil J, Weaver TE. 2010. Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda) 25:132–41.
  • Prentki M, Madiraju SRM. 2008. Glycerolipid metabolism and signaling in health and disease. Endocr Rev 29:647–76.
  • Przybytkowski E, Behrendt M, Dubois D, Maysinger D. 2009. Nanoparticles can induce changes in the intracellular metabolism of lipids without compromising cellular viability. FEBS J. 276:6204–17.
  • Pucer A, Brglez V, Payre C, Pungercar J, Lambeau G, Petan T. 2013. Group X secreted phospholipase A(2) induces lipid droplet formation and prolongs breast cancer cell survival. Mol Cancer 12:111.
  • Ratoi M, Hoet PHM, Crossley A, Dobson P. 2014. Impact of lung surfactant on wettability and cytotoxicity of nanoparticles. Rsc Adv 4:20573–81.
  • Repetto G, del Peso A, Zurita JL. 2008. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 3:1125–31.
  • Sadhukha T, Wiedmann TS, Panyam J. 2013. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials 34:5163–71.
  • Sarkar A, Ghosh M, Sil PC. 2014. Nanotoxicity: oxidative stress mediated toxicity of metal and metal oxide nanoparticles. J Nanosci Nanotechnol 14:730–43.
  • Schleh C, Kreyling WG, Lehr CM. 2013. Pulmonary surfactant is indispensable in order to simulate the in vivo situation. Part Fibre Toxicol 10:6.
  • Shayman JA, Abe A. 2013. Drug induced phospholipidosis: an acquired lysosomal storage disorder. Biochim Biophys Acta 1831:602–11.
  • Simon-Deckers A, Gouget B, Mayne-L'Hermite M, Herlin-Boime N, Reynaud C, Carriere M. 2008. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 253:137–46.
  • Singh S, Shi TM, Duffin R, Albrecht C, van Berlo D, Hoehr D, et al. 2007. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxicol Appl Pharm 222:141–51.
  • Stearns RC, Paulauskis JD, Godleski JJ. 2001. Endocytosis of ultrafine particles by A549 cells. Am J Respir Cell Mol Biol 24:108–15.
  • Stern ST, Adiseshaiah PP, Crist RM. 2012. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 9:20.
  • Wahajuddin AS. 2012. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine 7:3445–71.
  • Wang MJ, Petersen NO. 2013. Lipid-coated gold nanoparticles promote lamellar body formation in A549 cells. Biochim Biophys Acta 1831:1089–97.
  • Weaver TE, Na CL, Stahlman M. 2002. Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. Semin Cell Dev Biol 13:263–70.
  • Whitsett JA, Wert SE, Weaver TE. 2010. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 61:105–19.